Annual Operating Expenses
$242.78 M
+$46.61 M+23.76%
31 December 2023
Summary:
Castle Biosciences annual total operating expenses is currently $242.78 million, with the most recent change of +$46.61 million (+23.76%) on 31 December 2023. During the last 3 years, it has risen by +$183.28 million (+308.00%). CSTL annual operating expenses is now at all-time high.CSTL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$65.09 M
-$2.38 M-3.52%
30 September 2024
Summary:
Castle Biosciences quarterly total operating expenses is currently $65.09 million, with the most recent change of -$2.38 million (-3.52%) on 30 September 2024. Over the past year, it has increased by +$5.28 million (+8.83%). CSTL quarterly operating expenses is now -3.52% below its all-time high of $67.47 million, reached on 30 June 2024.CSTL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.8% | +8.8% |
| 3 y3 years | +308.0% | +111.4% |
| 5 y5 years | +1038.5% | +653.7% |
CSTL Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +308.0% | -3.5% | +111.4% |
| 5 y | 5 years | at high | +1038.5% | -3.5% | +653.7% |
| alltime | all time | at high | +1130.4% | -3.5% | +1148.8% |
Castle Biosciences Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $65.09 M(-3.5%) |
| June 2024 | - | $67.47 M(+4.5%) |
| Mar 2024 | - | $64.55 M(+8.8%) |
| Dec 2023 | $242.78 M(+23.8%) | $59.35 M(-0.8%) |
| Sept 2023 | - | $59.81 M(-0.7%) |
| June 2023 | - | $60.24 M(-5.0%) |
| Mar 2023 | - | $63.38 M(+22.0%) |
| Dec 2022 | $196.17 M(+65.8%) | $51.95 M(+4.2%) |
| Sept 2022 | - | $49.84 M(-3.3%) |
| June 2022 | - | $51.52 M(+20.2%) |
| Mar 2022 | - | $42.86 M(+20.4%) |
| Dec 2021 | $118.34 M | $35.61 M(+15.7%) |
| Sept 2021 | - | $30.79 M(+10.5%) |
| June 2021 | - | $27.87 M(+15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $24.07 M(+36.3%) |
| Dec 2020 | $59.51 M(+59.8%) | $17.66 M(+6.1%) |
| Sept 2020 | - | $16.64 M(+48.4%) |
| June 2020 | - | $11.21 M(-19.8%) |
| Mar 2020 | - | $13.99 M(+7.5%) |
| Dec 2019 | $37.23 M(+74.6%) | $13.01 M(+50.6%) |
| Sept 2019 | - | $8.64 M(+6.1%) |
| June 2019 | - | $8.14 M(+9.4%) |
| Mar 2019 | - | $7.44 M(+40.3%) |
| Dec 2018 | $21.32 M(+8.1%) | $5.30 M(+1.7%) |
| Sept 2018 | - | $5.21 M(-2.0%) |
| June 2018 | - | $5.32 M(-3.1%) |
| Mar 2018 | - | $5.49 M |
| Dec 2017 | $19.73 M | - |
FAQ
- What is Castle Biosciences annual total operating expenses?
- What is the all time high annual operating expenses for Castle Biosciences?
- What is Castle Biosciences annual operating expenses year-on-year change?
- What is Castle Biosciences quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Castle Biosciences?
- What is Castle Biosciences quarterly operating expenses year-on-year change?
What is Castle Biosciences annual total operating expenses?
The current annual operating expenses of CSTL is $242.78 M
What is the all time high annual operating expenses for Castle Biosciences?
Castle Biosciences all-time high annual total operating expenses is $242.78 M
What is Castle Biosciences annual operating expenses year-on-year change?
Over the past year, CSTL annual total operating expenses has changed by +$46.61 M (+23.76%)
What is Castle Biosciences quarterly total operating expenses?
The current quarterly operating expenses of CSTL is $65.09 M
What is the all time high quarterly operating expenses for Castle Biosciences?
Castle Biosciences all-time high quarterly total operating expenses is $67.47 M
What is Castle Biosciences quarterly operating expenses year-on-year change?
Over the past year, CSTL quarterly total operating expenses has changed by +$5.28 M (+8.83%)